InnAccel Technologies
Frugal medical devices for the next billion patients.
InnAccel is a MedTech start-up that has innovated three novel life-saving devices — affordable, clinically validated products built for emerging markets. It identifies critical gaps in patient care and designs, tests, and commercialises products across maternal health, critical care, and neonatal care that improve clinical outcomes at a fraction of imported device costs. Its customers are hospitals, government health systems, and healthcare providers, particularly in resource-constrained settings. In-house engineering, clinical validation, and manufacturing across multiple product lines set it apart within the medical devices category.
Frugal medtech is a decade-long game, and the InnAccel founders have the exact temperament for it — Stanford Biodesign training, deep clinical fieldwork, and a patents-first discipline. Their willingness to build slowly and correctly for the next billion patients is why we backed them. Very few Indian teams have shown they can carry a medical device from clinical insight through regulatory approvals to manufacturing at cost points that district hospitals can actually afford — InnAccel has done it repeatedly. That platform of engineering, clinical, and regulatory muscle is the compounding asset we're investing behind.
- 01
Portfolio of CE-marked and USFDA-cleared devices in obstetrics and critical care
- 02
In-house R&D lab producing multiple novel devices per year
- 03
Founder-led team with Stanford Biodesign lineage and 100+ patents
Building in the same category?
Pitch us →